20:22 , Oct 31, 2018 |  BC Innovations  |  Distillery Therapeutics

Renal

INDICATION: Renal Patient sample and mouse studies suggest inhibiting DAB2 could help treat chronic kidney disease (CKD). A comparison of expression quantitative trait loci (eQTL) analyses of glomerular and tubular compartments from 151 CKD patients...
07:00 , Jul 15, 2010 |  BC Innovations  |  Distillery Techniques

Technology: Markers

Approach Summary Licensing status Publication and contact information Markers Disabled homolog 2 (DAB2) as a biomarker for squamous cell carcinoma (SCC) progression DAB2 could be a useful biomarker for selecting SCC therapy. In primary tumor...